1 Mitoxantrone Market Overview 1.1 Product Overview and Scope of Mitoxantrone 1.2 Mitoxantrone Segment by Type 1.2.1 Global Mitoxantrone Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 20 mg/10 mL 1.2.3 25 mg/12.5 mL 1.2.4 30 mg/15 mL 1.3 Mitoxantrone Segment by Application 1.3.1 Global Mitoxantrone Sales Comparison by Application: (2021-2027) 1.3.2 Multiple Sclerosis (MS) 1.3.3 Cancer 1.4 Global Mitoxantrone Market Size Estimates and Forecasts 1.4.1 Global Mitoxantrone Revenue 2016-2027 1.4.2 Global Mitoxantrone Sales 2016-2027 1.4.3 Mitoxantrone Market Size by Region: 2016 Versus 2021 Versus 2027 2 Mitoxantrone Market Competition by Manufacturers 2.1 Global Mitoxantrone Sales Market Share by Manufacturers (2016-2021) 2.2 Global Mitoxantrone Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Mitoxantrone Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Mitoxantrone Manufacturing Sites, Area Served, Product Type 2.5 Mitoxantrone Market Competitive Situation and Trends 2.5.1 Mitoxantrone Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Mitoxantrone Players Market Share by Revenue 2.5.3 Global Mitoxantrone Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Mitoxantrone Retrospective Market Scenario by Region 3.1 Global Mitoxantrone Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Mitoxantrone Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Mitoxantrone Market Facts & Figures by Country 3.3.1 North America Mitoxantrone Sales by Country 3.3.2 North America Mitoxantrone Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Mitoxantrone Market Facts & Figures by Country 3.4.1 Europe Mitoxantrone Sales by Country 3.4.2 Europe Mitoxantrone Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Mitoxantrone Market Facts & Figures by Region 3.5.1 Asia Pacific Mitoxantrone Sales by Region 3.5.2 Asia Pacific Mitoxantrone Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Mitoxantrone Market Facts & Figures by Country 3.6.1 Latin America Mitoxantrone Sales by Country 3.6.2 Latin America Mitoxantrone Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Mitoxantrone Market Facts & Figures by Country 3.7.1 Middle East and Africa Mitoxantrone Sales by Country 3.7.2 Middle East and Africa Mitoxantrone Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Mitoxantrone Historic Market Analysis by Type 4.1 Global Mitoxantrone Sales Market Share by Type (2016-2021) 4.2 Global Mitoxantrone Revenue Market Share by Type (2016-2021) 4.3 Global Mitoxantrone Price by Type (2016-2021) 5 Global Mitoxantrone Historic Market Analysis by Application 5.1 Global Mitoxantrone Sales Market Share by Application (2016-2021) 5.2 Global Mitoxantrone Revenue Market Share by Application (2016-2021) 5.3 Global Mitoxantrone Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Pfizer 6.1.1 Pfizer Corporation Information 6.1.2 Pfizer Description and Business Overview 6.1.3 Pfizer Mitoxantrone Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Pfizer Mitoxantrone Product Portfolio 6.1.5 Pfizer Recent Developments/Updates 6.2 Mylan 6.2.1 Mylan Corporation Information 6.2.2 Mylan Description and Business Overview 6.2.3 Mylan Mitoxantrone Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Mylan Mitoxantrone Product Portfolio 6.2.5 Mylan Recent Developments/Updates 6.3 Teva 6.3.1 Teva Corporation Information 6.3.2 Teva Description and Business Overview 6.3.3 Teva Mitoxantrone Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Teva Mitoxantrone Product Portfolio 6.3.5 Teva Recent Developments/Updates 6.4 Fresenius Kabi 6.4.1 Fresenius Kabi Corporation Information 6.4.2 Fresenius Kabi Description and Business Overview 6.4.3 Fresenius Kabi Mitoxantrone Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Fresenius Kabi Mitoxantrone Product Portfolio 6.4.5 Fresenius Kabi Recent Developments/Updates 6.5 West-Ward Pharmaceuticals 6.5.1 West-Ward Pharmaceuticals Corporation Information 6.5.2 West-Ward Pharmaceuticals Description and Business Overview 6.5.3 West-Ward Pharmaceuticals Mitoxantrone Sales, Revenue and Gross Margin (2016-2021) 6.5.4 West-Ward Pharmaceuticals Mitoxantrone Product Portfolio 6.5.5 West-Ward Pharmaceuticals Recent Developments/Updates 6.6 Sichuan Sunnyhope Pharmaceutical 6.6.1 Sichuan Sunnyhope Pharmaceutical Corporation Information 6.6.2 Sichuan Sunnyhope Pharmaceutical Description and Business Overview 6.6.3 Sichuan Sunnyhope Pharmaceutical Mitoxantrone Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Sichuan Sunnyhope Pharmaceutical Mitoxantrone Product Portfolio 6.6.5 Sichuan Sunnyhope Pharmaceutical Recent Developments/Updates 6.7 Shandong Luoxin Pharmaceutical 6.6.1 Shandong Luoxin Pharmaceutical Corporation Information 6.6.2 Shandong Luoxin Pharmaceutical Description and Business Overview 6.6.3 Shandong Luoxin Pharmaceutical Mitoxantrone Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Shandong Luoxin Pharmaceutical Mitoxantrone Product Portfolio 6.7.5 Shandong Luoxin Pharmaceutical Recent Developments/Updates 6.8 Baxter 6.8.1 Baxter Corporation Information 6.8.2 Baxter Description and Business Overview 6.8.3 Baxter Mitoxantrone Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Baxter Mitoxantrone Product Portfolio 6.8.5 Baxter Recent Developments/Updates 7 Mitoxantrone Manufacturing Cost Analysis 7.1 Mitoxantrone Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Mitoxantrone 7.4 Mitoxantrone Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Mitoxantrone Distributors List 8.3 Mitoxantrone Customers 9 Mitoxantrone Market Dynamics 9.1 Mitoxantrone Industry Trends 9.2 Mitoxantrone Growth Drivers 9.3 Mitoxantrone Market Challenges 9.4 Mitoxantrone Market Restraints 10 Global Market Forecast 10.1 Mitoxantrone Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Mitoxantrone by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Mitoxantrone by Type (2022-2027) 10.2 Mitoxantrone Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Mitoxantrone by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Mitoxantrone by Application (2022-2027) 10.3 Mitoxantrone Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Mitoxantrone by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Mitoxantrone by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Mitoxantrone Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Mitoxantrone Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Mitoxantrone Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Mitoxantrone Covered in This Study Table 5. Global Mitoxantrone Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Mitoxantrone Sales Market Share by Manufacturers (2016-2021) Table 7. Global Mitoxantrone Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Mitoxantrone Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Mitoxantrone Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Mitoxantrone Manufacturing Sites and Area Served Table 11. Manufacturers Mitoxantrone Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Mitoxantrone by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mitoxantrone as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Mitoxantrone Sales by Region (2016-2021) & (K Units) Table 16. Global Mitoxantrone Sales Market Share by Region (2016-2021) Table 17. Global Mitoxantrone Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Mitoxantrone Sales by Country (2016-2021) & (K Units) Table 19. North America Mitoxantrone Sales Market Share by Country (2016-2021) Table 20. North America Mitoxantrone Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Mitoxantrone Revenue Market Share by Country (2016-2021) Table 22. Europe Mitoxantrone Sales by Country (2016-2021) & (K Units) Table 23. Europe Mitoxantrone Sales Market Share by Country (2016-2021) Table 24. Europe Mitoxantrone Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Mitoxantrone Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Mitoxantrone Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Mitoxantrone Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Mitoxantrone Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Mitoxantrone Revenue Market Share by Region (2016-2021) Table 30. Latin America Mitoxantrone Sales by Country (2016-2021) & (K Units) Table 31. Latin America Mitoxantrone Sales Market Share by Country (2016-2021) Table 32. Latin America Mitoxantrone Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Mitoxantrone Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Mitoxantrone Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Mitoxantrone Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Mitoxantrone Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Mitoxantrone Revenue Market Share by Country (2016-2021) Table 38. Global Mitoxantrone Sales (K Units) by Type (2016-2021) Table 39. Global Mitoxantrone Sales Market Share by Type (2016-2021) Table 40. Global Mitoxantrone Revenue (Million US$) by Type (2016-2021) Table 41. Global Mitoxantrone Revenue Share by Type (2016-2021) Table 42. Global Mitoxantrone Price (USD/Unit) by Type (2016-2021) Table 43. Global Mitoxantrone Sales (K Units) by Application (2016-2021) Table 44. Global Mitoxantrone Sales Market Share by Application (2016-2021) Table 45. Global Mitoxantrone Revenue (Million US$) by Application (2016-2021) Table 46. Global Mitoxantrone Revenue Share by Application (2016-2021) Table 47. Global Mitoxantrone Price (USD/Unit) by Application (2016-2021) Table 48. Pfizer Corporation Information Table 49. Pfizer Description and Business Overview Table 50. Pfizer Mitoxantrone Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Pfizer Mitoxantrone Product Table 52. Pfizer Recent Developments/Updates Table 53. Mylan Corporation Information Table 54. Mylan Description and Business Overview Table 55. Mylan Mitoxantrone Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Mylan Mitoxantrone Product Table 57. Mylan Recent Developments/Updates Table 58. Teva Corporation Information Table 59. Teva Description and Business Overview Table 60. Teva Mitoxantrone Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. Teva Mitoxantrone Product Table 62. Teva Recent Developments/Updates Table 63. Fresenius Kabi Corporation Information Table 64. Fresenius Kabi Description and Business Overview Table 65. Fresenius Kabi Mitoxantrone Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Fresenius Kabi Mitoxantrone Product Table 67. Fresenius Kabi Recent Developments/Updates Table 68. West-Ward Pharmaceuticals Corporation Information Table 69. West-Ward Pharmaceuticals Description and Business Overview Table 70. West-Ward Pharmaceuticals Mitoxantrone Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. West-Ward Pharmaceuticals Mitoxantrone Product Table 72. West-Ward Pharmaceuticals Recent Developments/Updates Table 73. Sichuan Sunnyhope Pharmaceutical Corporation Information Table 74. Sichuan Sunnyhope Pharmaceutical Description and Business Overview Table 75. Sichuan Sunnyhope Pharmaceutical Mitoxantrone Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. Sichuan Sunnyhope Pharmaceutical Mitoxantrone Product Table 77. Sichuan Sunnyhope Pharmaceutical Recent Developments/Updates Table 78. Shandong Luoxin Pharmaceutical Corporation Information Table 79. Shandong Luoxin Pharmaceutical Description and Business Overview Table 80. Shandong Luoxin Pharmaceutical Mitoxantrone Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 81. Shandong Luoxin Pharmaceutical Mitoxantrone Product Table 82. Shandong Luoxin Pharmaceutical Recent Developments/Updates Table 83. Baxter Corporation Information Table 84. Baxter Description and Business Overview Table 85. Baxter Mitoxantrone Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 86. Baxter Mitoxantrone Product Table 87. Baxter Recent Developments/Updates Table 88. Production Base and Market Concentration Rate of Raw Material Table 89. Key Suppliers of Raw Materials Table 90. Mitoxantrone Distributors List Table 91. Mitoxantrone Customers List Table 92. Mitoxantrone Market Trends Table 93. Mitoxantrone Growth Drivers Table 94. Mitoxantrone Market Challenges Table 95. Mitoxantrone Market Restraints Table 96. Global Mitoxantrone Sales Forecast by Type (2022-2027) & (K Units) Table 97. Global Mitoxantrone Sales Market Share Forecast by Type (2022-2027) Table 98. Global Mitoxantrone Revenue Forecast by Type (2022-2027) & (US$ Million) Table 99. Global Mitoxantrone Revenue Market Share Forecast by Type (2022-2027) Table 100. Global Mitoxantrone Sales Forecast by Application (2022-2027) & (K Units) Table 101. Global Mitoxantrone Sales Market Share Forecast by Application (2022-2027) Table 102. Global Mitoxantrone Revenue Forecast by Application (2022-2027) & (US$ Million) Table 103. Global Mitoxantrone Revenue Market Share Forecast by Application (2022-2027) Table 104. Global Mitoxantrone Sales Forecast by Region (2022-2027) & (K Units) Table 105. Global Mitoxantrone Sales Market Share Forecast by Region (2022-2027) Table 106. Global Mitoxantrone Revenue Forecast by Region (2022-2027) & (US$ Million) Table 107. Global Mitoxantrone Revenue Market Share Forecast by Region (2022-2027) Table 108. Research Programs/Design for This Report Table 109. Key Data Information from Secondary Sources Table 110. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Mitoxantrone Figure 2. Global Mitoxantrone Market Share by Type in 2020 & 2027 Figure 3. 20 mg/10 mL Product Picture Figure 4. 25 mg/12.5 mL Product Picture Figure 5. 30 mg/15 mL Product Picture Figure 6. Global Mitoxantrone Market Share by Application in 2020 & 2027 Figure 7. Multiple Sclerosis (MS) Figure 8. Cancer Figure 9. Global Mitoxantrone Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Mitoxantrone Market Size 2016-2027 (US$ Million) Figure 11. Global Mitoxantrone Sales 2016-2027 (K Units) Figure 12. Global Mitoxantrone Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Mitoxantrone Sales Share by Manufacturers in 2020 Figure 14. Global Mitoxantrone Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Mitoxantrone Players: Market Share by Revenue in 2020 Figure 16. Mitoxantrone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Mitoxantrone Sales Market Share by Region (2016-2021) Figure 18. Global Mitoxantrone Sales Market Share by Region in 2020 Figure 19. Global Mitoxantrone Revenue Market Share by Region (2016-2021) Figure 20. Global Mitoxantrone Revenue Market Share by Region in 2020 Figure 21. U.S. Mitoxantrone Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Mitoxantrone Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Germany Mitoxantrone Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. France Mitoxantrone Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. U.K. Mitoxantrone Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Italy Mitoxantrone Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Russia Mitoxantrone Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. China Mitoxantrone Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Japan Mitoxantrone Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. South Korea Mitoxantrone Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. India Mitoxantrone Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Australia Mitoxantrone Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Taiwan Mitoxantrone Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Mitoxantrone Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Mitoxantrone Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Mitoxantrone Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Philippines Mitoxantrone Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Vietnam Mitoxantrone Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Mexico Mitoxantrone Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Brazil Mitoxantrone Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Argentina Mitoxantrone Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Turkey Mitoxantrone Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Saudi Arabia Mitoxantrone Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. U.A.E Mitoxantrone Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Sales Market Share of Mitoxantrone by Type (2016-2021) Figure 46. Sales Market Share of Mitoxantrone by Application (2016-2021) Figure 47. Sales Market Share of Mitoxantrone by Application in 2020 Figure 48. Revenue Share of Mitoxantrone by Application (2016-2021) Figure 49. Revenue Share of Mitoxantrone by Application in 2020 Figure 50. Manufacturing Cost Structure of Mitoxantrone Figure 51. Manufacturing Process Analysis of Mitoxantrone Figure 52. Mitoxantrone Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Pfizer Mylan Teva Fresenius Kabi West-Ward Pharmaceuticals Sichuan Sunnyhope Pharmaceutical Shandong Luoxin Pharmaceutical Baxter